Highland Medical P.C. | Hematology Oncology Associates of Rockland

Research site
255 Fifth Avenue, Nyack, New York, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


4 of 16
Status: Active
Trial type: Interventional
Funder type: Industry

A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)

The purpose of this study is to evaluate the safety and efficacy of two parsaclisib treatment regimens in participants diagnosed with relapsed or ref...

Active, not recruiting
Drug: Parsaclisib

A study to learn about a new medicine called ARV-471 (PF-07850327) in people who have advanced metastatic breast cancer.

Advanced Breast Cancer
Drug: Fulvestrant
Drug: ARV-471

The main purpose of this study is to evaluate the efficacy and safety of M281 in participants with warm autoimmune hemolytic anemia (wAIHA).

Warm Autoimmune Hemolytic Anemia
Drug: M281
Drug: Placebo

This is a Phase 2, open-label, multicenter, multiple subcutaneous injection, safety and efficacy study of PF-06835375 in adult participants with prim...

Primary Immune Thrombocytopenia
Biological: PF-06835375

Trial conditions

Breast Cancer (4 trials)
Lung Cancer (4 trials)
Non-Small-Cell Lung Carc... (3 trials)
Anemia (1 trial)
Autoimmune Hemolytic Ane... (1 trial)
B-Cell Chronic Lymphocyt... (1 trial)
Carcinoma (1 trial)
Hemolysis (1 trial)
Hemolytic Anemia (1 trial)
Idiopathic Thrombocytope... (1 trial)

And 9 more

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems